A Phase II Study of Submandibular Salivary Gland Transfer to the Submental Space Prior to Start of Radiation Treatment for Prevention of Radiation-induced Xerostomia in Head and Neck Cancer Patients: Initial Report of RTOG-0244

被引：0

作者：

Jha, N. ^{[1
]}

Harris, J. ^{[2
]}

Seikaly, H. ^{[3
]}

Jacobs, J. ^{[4
]}

McEwan, A. ^{[1
]}

Robbins, K. T. ^{[5
]}

Grecula, J. ^{[6
]}

Sharma, A. ^{[7
]}

Ang, K. K. ^{[8
]}

机构：

[1] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada

[2] Radiat Therapy Oncol Grp, Philadelphia, PA USA

[3] Univ Alberta, Edmonton, AB, Canada

[4] Wayne State Univ, Sch Med, Detroit, MI USA

[5] St Johns Hosp, Inst Canc, Springfield, IL USA

[6] Ohio State Univ, Med Ctr, Columbus, OH 43210 USA

[7] Med Univ S Carolina, Charleston, SC 29425 USA

[8] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2010年 / 78卷 / 03期

关键词：

D O I：

10.1016/j.ijrobp.2010.07.219

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S80 / S81

页数：2

共 47 条

[31] Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: A double-blind randomized study in head and neck cancer patients
Carvalho, P. A. G.
Jaguar, G. C.
Pellizzon, A. C.
Prado, J. D.
Lopes, R. N.
Alves, F. A.
ORAL ONCOLOGY, 2011, 47 (12) : 1176 - 1181
[32] A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, DOSE-TITRATION STUDY OF ORAL PILOCARPINE FOR TREATMENT OF RADIATION-INDUCED XEROSTOMIA IN HEAD AND NECK-CANCER PATIENTS
LEVEQUE, FG
MONTGOMERY, M
POTTER, D
ZIMMER, MB
RIEKE, JW
STEIGER, BW
GALLAGHER, SC
MUSCOPLAT, CC
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) : 1124 - 1131
[33] The Indian Spice Turmeric Delays and Mitigates Radiation-Induced Oral Mucositis in Patients Undergoing Treatment for Head and Neck Cancer: An Investigational Study
Rao, Suresh
Dinkar, Chetana
Vaishnav, Lalit Kumar
Rao, Pratima
Rai, Manoj Ponadka
Fayad, Raja
Baliga, Manjeshwar Shrinath
INTEGRATIVE CANCER THERAPIES, 2014, 13 (03) : 201 - 210
[34] A RANDOMIZED PHASE II TRIAL COMPARING STANDARD PAIN CONTROL WITH OR WITHOUT GABAPENTIN FOR THE TREATMENT OF PAIN RELATED TO RADIATION-INDUCED MUCOSITIS IN HEAD AND NECK CANCER
Kataoka, T.
Kiyota, N.
Shimada, T.
Toyoda, M.
Fujiwara, Y.
Nibu, K.
Komori, T.
Sasaki, R.
Mukohara, T.
Minami, H.
ANNALS OF ONCOLOGY, 2012, 23 : 510 - 510
[35] Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial
Rajesh V. Lalla
Sebastián Solé
Sergio Becerra
Claudia Carvajal
Piero Bettoli
Hernán Letelier
Alejandro Santini
Lorena Vargas
Alexander Cifuentes
Francisco Larsen
Natalia Jara
Jorge Oyarzún
Richard Feinn
Eva Bustamante
Benjamín Martínez
David Rosenberg
Tomas Galván
Supportive Care in Cancer, 2020, 28 : 5871 - 5879
[36] Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial
Lalla, Rajesh V.
Sole, Sebastian
Becerra, Sergio
Carvajal, Claudia
Bettoli, Piero
Letelier, Hernan
Santini, Alejandro
Vargas, Lorena
Cifuentes, Alexander
Larsen, Francisco
Jara, Natalia
Oyarzun, Jorge
Feinn, Richard
Bustamante, Eva
Martinez, Benjamin
Rosenberg, David
Galvan, Tomas
SUPPORTIVE CARE IN CANCER, 2020, 28 (12) : 5871 - 5879
[37] A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients
Rossana Ingargiola
Maria Carmen De Santis
Nicola Alessandro Iacovelli
Nadia Facchinetti
Anna Cavallo
Eliana Ivaldi
Michela Dispinzieri
Marzia Franceschini
Carlotta Giandini
Domenico Attilio Romanello
Simona Di Biaso
Michela Sabetti
Laura Locati
Salvatore Alfieri
Paolo Bossi
Mauro Guglielmo
Fabio Macchi
Laura Lozza
Riccardo Valdagni
Carlo Fallai
Emanuele Pignoli
Ester Orlandi
Radiation Oncology, 15
[38] A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients
Ingargiola, Rossana
De Santis, Maria Carmen
Iacovelli, Nicola Alessandro
Facchinetti, Nadia
Cavallo, Anna
Ivaldi, Eliana
Dispinzieri, Michela
Franceschini, Marzia
Giandini, Carlotta
Romanello, Domenico Attilio
Di Biaso, Simona
Sabetti, Michela
Locati, Laura
Alfieri, Salvatore
Bossi, Paolo
Guglielmo, Mauro
Macchi, Fabio
Lozza, Laura
Valdagni, Riccardo
Fallai, Carlo
Pignoli, Emanuele
Orlandi, Ester
RADIATION ONCOLOGY, 2020, 15 (01)
[39] Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study
Kathrine Kronberg Jakobsen
Amanda-Louise Fenger Carlander
Christian Grønhøj
Tobias Todsen
Jacob Melchiors
Natasja Paaske
Anne Kathrine Østergaard Madsen
Jens Kastrup
Annette Ekblond
Mandana Haack-Sørensen
Mohammad Farhadi
Christian Maare
Jeppe Friborg
Charlotte Duch Lynggard
Christian von Buchwald
Trials, 24
[40] Effectiveness and safety of mesenchymal stem/stromal cell for radiation-induced hyposalivation and xerostomia in previous head and neck cancer patients (MESRIX-III): a study protocol for a single-centre, double-blinded, randomised, placebo-controlled, phase II study
Jakobsen, Kathrine Kronberg
Carlander, Amanda-Louise Fenger
Gronhoj, Christian
Todsen, Tobias
Melchiors, Jacob
Paaske, Natasja
Madsen, Anne Kathrine ostergaard
Kastrup, Jens
Ekblond, Annette
Haack-Sorensen, Mandana
Farhadi, Mohammad
Maare, Christian
Friborg, Jeppe
Lynggard, Charlotte Duch
von Buchwald, Christian
TRIALS, 2023, 24 (01)

← 1 2 3 4 5 →